One potentially valuable pathogenic clue is the female dominance, with nine out of 10 patients being women (19) . Most of the patients develop their disease at the time of menopause upon cessation of ovarial estrogen synthesis. It has been suggested that estrogens inhibit T cell-mediated immune reactions but promote B cell-mediated immunity (6) . Another angle of view suggests that the hormonal changes at the time of menopause could affect the exocrine target tissue of this organ-specific autoimmune disease (12) . Ovariectomized, estrogen-deficient mice develop epithelial cell apoptosis in submandibular salivary glands (SMGs), which leads to a SS-like autoimmune exocrinopathy (13, 14) . Consistently, aromatase (an enzyme responsible for the key step in the biosynthesis of estrogens) knockout in mice (34) and aromatase inhibitor treatment in women with breast cancer (23) also lead to SS-like features. Low concentration of salivary 17␤-estradiol (E 2 ; the most active estrogen) was shown to correlate with dry mouth feeling in menopausal women (1) . Altogether, these studies imply a protective estrogen effect in SS. Interestingly, neither ER␣ nor ER␤ seems to be directly involved in the exocrinopathy of the salivary glands in mice (35) .
Beside the strong evidence that estrogens play a role in autoimmune exocrinopathy and SS, one important question from three different angles remains:1) Why do not all women during the menopause develop SS; 2) why do male mice not always develop such target tissue-specific apoptosis, because compared with female mice they are estrogen deficient; and 3) why do so few men develop SS? We hypothesized that this could be due to the protective effects of androgens against estrogen deficiency-induced SMG serous epithelial cell apoptosis. In male mice and men it clearly makes sense because healthy adults and even aging males have relatively high testosterone levels compared with women. Furthermore, expression of androgen receptors has been demonstrated in salivary glands of different species, including humans and rodents (21, 32, 43) , strongly suggesting that they form a target for the action of androgens.
To test the working hypothesis that androgens protect salivary epithelial cells against apoptosis in males (with normally low estrogen levels), we analyzed the submandibular glands in orchiectomized (ORX) wild-type (WT) and androgen receptor knockout (ARKO) mice. The experiment was designed to assess whether exogenously administered dehydroepiandrosterone (DHEA) provides a salvage route in WT ORX mice, which do not produce testosterone but have androgen receptors and are therefore responsive to active androgens, e.g., testosterone and in particular dihydrotestosterone (DHT).
MATERIALS AND METHODS
Cell culture and stimulations. Epithelial human submandibular gland (HSG) cells (36) were cultured in DMEM-F-12 Nut Mix medium (Gibco) supplemented with 10% fetal calf serum, 2 mM glutamine, 100 IU/ml penicillin, and 100 g/ml streptomycin.
Cells were cultured with and without DHEA (100 nM, 1 M) (Sigma, St. Louis, MO) or DHT (0.5 nM, 10 nM, 100 nM, and 1 M) (Sigma) in serum-free medium for 24 h before the induction of apoptosis. Apoptosis was induced by a 4-h-long treatment with 10 ng/ml tumor necrosis factor-␣ (TNF␣; R & D Systems) and 10 g/ml cycloheximide (CHX; Sigma) (41) . Induction of apoptosis by TNF␣/ CHX treatment was confirmed by Apoptotic/Necrotic/Healthy Cells Detection Kit (PromoKine, Heidelberg, Germany), and viability of the cells after hormonal and apoptotic treatments was assessed using the Live-Dead staining kit (Invitrogen).
Animals and experimental design. WT male C57BL/6 (Scanbur, NOVA-SCB, Sollentuna, Sweden) and ARKO mice (n ϭ 7; backcrossed 6 times onto a C57BL/6background) were kept under standard environmental conditions in cages with five to 10 animals and were fed with standard laboratory chow and tap water ad libitum. We assessed androgen receptor (AR) genotype by PCR amplification of genomic DNA (7) .
ORX surgeries were performed at 3 wk of age. Surgery was performed after anesthesia with ketamine (PfizerAB, Täby, Sweden) and medetomidin (OrionPharma, Espoo, Finland). Carprofen (OrionPharma, Espoo, Finland) was used postoperatively as a painkiller.
WT and ARKO mice (ORX or sham operated) were treated with DHEA or with placebo. DHEA-treated mice received 5 days/wk subcutaneous injections of DHEA (2 mg·mouse Ϫ1 ·day Ϫ1 ; Sigma) dissolved in 100 l vehicle Miglyol812 (OmyaPeralta GmbH, Hamburg, Germany), and placebo-treated mice received only the Migloyol (vehicle). Treatment started 10 days after ORX operation and continued for 2.5 wk until mice were terminated.
The present study included five animals in each treatment group: ARKO ORX placebo-treated, ARKO ORX DHEA-treated, WT ORX placebo-treated, WT ORX DHEA-treated, and WT sham-operated placebo-treated group. All animals were euthanized at 2 mo of age for further analysis.
All procedures were approved by the ethics committee for animal experiments at the University of Gothenburg.
Tissue collection and processing. Submandibular, parotid, and sublingual salivary glands were collected and immediately frozen in liquid nitrogen or fixed in 10% formalin for preparation of frozen and paraffin tissue sections, respectively.
Alcian blue-periodic acid Schiff staining. Alcian blue (AB) stains acid mucopolysaccharides blue, and periodic acid Schiff (PAS) stains neutral mucopolysaccharides magenta, whereas mixtures of acid and neutral mucopolysaccharides stain purple. Five-micrometer paraffin sections were stained with 1% AB in 3% aqueous acetic acid, pH 2.2, for 5 min and washed in running tap water for 10 min before immersion in 1% aqueous periodic acid for 5 min. After washing in distilled H 2O for 10 min, sections were stained with PAS for 15 min and washed in running tap water for 10 min before nuclei were lightly stained with hematoxylin (4).
Immunohistochemical staining. Polyclonal rabbit anti-human IgG against activated (cleaved) caspase-3 (Cell Signaling Technology) does not recognize full-length caspase-3 or other cleaved caspases and also cross-reacts with the corresponding mouse antigen. Rabbit monoclonal anti-human cleaved caspase-8 IgG (Cell Signaling Technology), which also cross-reacts with the corresponding mouse antigen, detects cleaved caspase-8. An affinity-purified polyclonal goat antihuman salivary ␣-amylase IgG (sc-12821, C-20; Santa Cruz Biotechnology, Santa Cruz, CA) was used as a serous cell marker. This antibody was raised against synthetic peptide corresponding to the amino acids 460 -510 at the COOH terminus of the human amylase and also cross-reacted with the corresponding mouse antigen. Polyclonal rabbit anti-human cysteine-rich secretory protein-3 (CRISP-3; also known as SGP28) IgG was raised against the recombinant COOH-terminally truncated form of CRISP-3 and also cross-reacts with the corresponding mouse antigen (Hycult Biotech, Uden, The Netherlands). Polyclonal rabbit anti-human SLC39A6/leucine-isoleucine-valine transport system 1 (LIV-1) IgG antibodies were raised against synthetic peptide corresponding to the amino acids 295-344 of human SLC39A6 (Abcam ab61307; Abcam, Cambridge, UK) and cross-also reacted with the corresponding mouse antigen. Polyclonal goat anti-human anti-␣-smooth muscle actin (␣-SMA) IgG (EB-06450; Everest Biotech, Oxfordshire, UK) raised against peptide corresponding to the NH 2 terminus of the protein was used as a myoepithelial cell marker. This antibody also cross-reacted with the corresponding mouse antigen.
Four-micrometer-thick paraffin tissue sections (fixed in 10% formalin) were rehydrated in decreasing ethanol series and washed in 10 mM Tris buffer and 150 mM NaCl, pH 7.5. Antigen retrieval was performed by incubating slides in 10 mM sodium citrate solution, pH 6.0, in a microwave oven (Micromed T/T Mega, a microwave processing laboratory station for Histology; Hacker Instruments & Industries, Winnsboro, SC). Tissue sections were cooled down and washed in PBS for 3 ϫ 5 min at ϩ22°C. Blocking of endogenous peroxidase was done in 1% hydrogen peroxide in PBS for 15 min, followed by washes in PBS for 3 ϫ 5 min . Tissue sections were incubated in 10% normal serum (from the species used to produce the secondary antibodies) for 1 h at ϩ22°C. Slides were incubated in a primary 1 g/ml anti-CRISP-3, 2 g/ml anti-␣-SMA, 0.5 g/ml anti-cleaved caspase-3, 0.5 g/ml anti-cleaved caspase-8, and 1 g/ml anti-amylase IgG overnight at ϩ4°C and washed for 3 ϫ 5 min in PBS. Secondary antibody (biotinylated IgG rabbit anti-goat or goat anti-rabbit as appropriate) diluted 1:200 in 0.1% BSA-PBS was applied for 1 h at ϩ22°C, followed by PBS wash for 3 ϫ 5 min, incubated with avidin-biotin peroxidase complex (Vectastain ABC HRP Elite Kit; Vector Laboratories, Burlingame, CA), washed for 3 ϫ 5 min in PBS, incubated in 0.006% H2O2 substrate and 3,3=-diaminobenzidine chromogen for 10 min at ϩ22°C and washed in dH2O, counterstained in hematoxylin, washed in running tap water for 5 min, dehydrated in a graded ethanol series, cleared in xylene, and mounted in Mountex (Histolab, Gothenburg, Sweden) before microscopy.
Immunofluorescence and double-immunofluorescence staining. Fourmicrometer-thick paraffin sections were, after deparaffinization and antigen retrieval as described above, cooled down and washed for 2 ϫ 5 min in PBS and 1 ϫ 5 min in PBS solution with 0.5% Triton X-100 at ϩ22°C. Blocking of nonspecific binding was done using 10% normal donkey serum, as described above. Sections were incubated in 1 g/ml rabbit anti-human CRISP-3 IgG (Hycult) and 2 g/ml goat anti-human ␣-SMA IgG and washed 3 ϫ 5 min in PBS. Tissue slides were incubated in Alexa fluor 488-conjugated donkey anti-rabbit immunoglobulin and Alexa fluor 568-conjugated donkey anti-goat IgG (Molecular Probes and Invitrogen, Carlsbad, CA) for 1 h at ϩ22°C and washed 3 ϫ 5 min in PBS. DAPI (4,6-diamino-2-phenylindole dihydrochloride; Sigma D9542) diluted 1:1,000 in dH2O was added for 5 min at ϩ22°C, followed by 3 ϫ 5 min in PBS. Tissue sections were mounted in Slow Fade Gold antifade reagent (Moleclular Probes and Invitrogen).
Terminal deoxynucleotidyl transferase dUTP nick end labeling. Apoptotic cell death in salivary tissues of the animals used in the study was evaluated with terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) Universal Apoptosis Detection Kit (Biotin-labeled POD; Genscript USA, Piscataway, NJ). Staining was done on 4-m-thick paraffin tissue sections. TUNEL assay, including preparation of positive control (treatment with DNase I prior to the labeling procedure) and negative control (labeling without terminal deoxynucleotidyl transferase), was done according to the manufacturer's instructions.
Light and immunofluorescence microscopy and imaging. Immunohistochemical (IHC) and AB-PAS-stained sections were studied under a light microscope (Leitz Diaplan, Wetzlar, Germany) connected to a digital camera (Leica DFC420). Immunofluorescence-stained sections were analyzed under an immunofluorescence microscope (Olympus AX 70; Olympus, Tokyo, Japan) equipped with a 12-bit digital camera (PCO CCD SensiCam, Kelheim, Germany). All pictures were taken at ϫ400 magnification.
Transmission electron microscopy and imaging. Paraffin-embedded SMG samples (ARKO ORX, n ϭ 3; WT ORX DHEA, n ϭ 2; and WT sham, n ϭ 2) were deparaffinized, rehydrated in 0.5 M cacodylic acid, and, as formalin fixed tissues [the conventional protocol for transmission electron microscopy (TEM) samples], fixed in 5% glutaraldehyde (Agar Scientific Elektron Technology, Stansted, UK) buffered in 0.5 M cacodylic acid. Tissue cubicles (1 mm) were postfixed in 1% osmium tetroxide and embedded in epoxy resin (TAAB Laboratories Equipment, Aldermaston, UK). Toluidine-blue stained, 0.5-m-thick semithin sections were used for selecting relevant areas for 75-nm ultrathin sections contrasted with lead citrate and uranyl acetate. Sections were examined under a Phillips EM208S (FEI UK, Cambridge, UK) at 80 kV equipped with a charge-coupled device camera (Gatan, ES500W Erlangshen). Pictures were taken at ϫ3,500 and ϫ14,000 magnifications.
RESULTS

Viability of HSG cells in vitro.
TNF␣/CHX treatment was confirmed to induce apoptosis in HSG cells, which was shown by annexin V staining (data not shown). Pretreatment of HSG cells with DHT (0.5 nM, 10 nM, 100 nM, and 1 M; P ϭ 0.017) protected the cells from TNF␣/CHX-induced cell death (Fig. 1) . Pretreatment with DHT before TNF␣/CHX treatment increased the percentage of living cells from from 11.9 to 25.8 (0.5 nM DHT, P ϭ 0.018), 26.7 (10 nM DHT, P ϭ 0.004), 20 (100 nM DHT, P ϭ 0.009), or 23.4% (1 M DHT; P ϭ 0.01). Also, treatment with 1 M DHEA showed a tendency to increase the percentage of living cells from 11.9 to 22.4%, but the difference was not significant.
Apoptosis of epithelial SMG cells in vivo: cleaved caspase-3 and caspase-8 IHC and TUNEL staining. The expression patterns of these two cleaved caspases were strikingly similar. In WT ORX, and in particular in ARKO ORX mice without or with DHEA treatment, cleaved caspase-3 and cleaved caspase-8 were strongly expressed in extracellular vesicles secreted from SMG serous epithelial cells to salivary ducts. There was no cleaved caspase-3 or cleaved caspase-8 staining of the nuclei of the serous epithelial cells (Figs. 2, A-C, and 3, A-C) . In contrast to androgen effect-deficient mice, cleaved caspase-3 and cleaved caspase-8 were absent in WT sham mice (Fig. 2E and data not shown, respectively). Consistently, when androgen-deficient WT ORX mice were treated with DHEA, which in an intracrine process can be converted to the active androgen DHT, or the active estrogen E2, cleaved caspase-3 and cleaved caspase-8 were mostly absent (Figs. 2D and 3D) . Sporadically, some SMG serous epithelial cells in WT ORX DHEA mice showed cytoplasmic staining for cleaved caspase-3 and cleaved caspase-8 [supporting information is available from the corresponding author (yrjö.konttinen@helsinki.fi)].
Strong TUNEL staining was detected only in positive control SMG samples and treated with DNase I prior to the labeling procedure. In contrast, there were hardly any TUNELstained nuclei in SMGs in WT sham, ORX DHEA, and androgen-deficient mice (ARKO ORX, ARKO ORX DHEA, and WT ORX; data not shown).
AB-PAS staining. In WT sham mice, serous epithelial cells rich in neutral mucopolysaccharides assumed magenta color (and were thus PAS positive). Mucous acinar cells rich in acid mucopolysaccharides were blue. In DHEA-treated WT ORX mice, serous cells were normal and stained magenta due to their PAS reactivity (Fig. 5D) . In contrast, androgen-deficient mice serous salivary epithelial cells were mostly PAS negative (AB positive), small in size, and reduced in number (Fig. 5, A-C) .
Amylase IHC staining. Staining of serous acinar marker amylase was strongest in serous epithelial cells of DHEAtreated WT ORX control mice with restored androgen effect (Fig. 6D) . In contrast, only weak or no staining was detected in mice that lacked androgen effect (Fig. 6, A-C) .
CRISP-3 IHC staining. In WT ORX mice, DHEA treatment restored the androgen effect so that a very strong CRISP-3 staining was seen in serous epithelial cells (Fig. 8D) . In the androgen-deficient mice (in ARKO ORX, ARKO ORX DHEA, and WT ORX mice), CRISP-3 staining of the serous epithelial cells was very weak or totally missing (Fig. 8, A-C) .
Myoepithelial cells were CRISP-3 positive independent of androgen effect. Colocalization of CRISP-3 and ␣-SMA in myoepithelial SMG cells in both WT ORX and WT ORX DHEA mice was shown by double-immunofluorescent staining [supporting information is available from the corresponding author (yrjö.konttinen@helsinki.fi)].
LIV-1 IHC staining. Estrogen dependent LIV-1 expression was low in all samples, but it still revealed a slight difference in staining results. Namely, LIV-1 signal was strongest in serous salivary epithelial cells and ducts of DHEA-treated ARKO ORX mice (Fig. 9B) , whereas in untreated ARKO ORX mice there was hardly any LIV-1 signal (Fig. 9A) .
TEM. In serous SMG cells of androgen-deficient ARKO ORX mice, TEM revealed extracellular 30-to 100-nm vesicles similar in size to exosomes (Fig. 4A) and only a few large electron-dense intracellular secretory granules (Fig. 7A) . In contrast to ARKO ORX mice, a smaller number of extracellular exosome-like vesicles and a significantly larger number of electron-dense intracellular secretory granules were detected in serous cells of DHEA-treated WT ORX (Figs. 4B and 7B ) and WT sham mice (data not shown).
DISCUSSION
Herein, we tested the hypothesis that androgens protect epithelial SMG cells against apoptosis induced by estrogen deficiency. First, we demonstrated in vitro that DHT inhibits epithelial HSG cell death induced with TNF␣ and cycloheximide. Next, we tested the in vivo effect of androgen deficiency on salivary glands in WT ORX male mice. To ensure that inhibition of the androgen effect was complete, we also used ARKO ORX mice without and with DHEA treatment. In addition, we analyzed whether a similar apoptosis pattern was present in sham-WT sibling control mice and in particular whether the presumptive apoptosis could be prevented in WT ORX mice by DHEA (which undergoes an intracrine DHEA-DHT conversion).
We found that androgen deficiency had a strong effect on SMGs, whereas parotid and sublingual salivary glands appeared to be unaffected (not shown). We showed that SMG expression of cleaved caspase-3 and caspase-8 was strongly induced in androgen effect-deficient (ARKO ORX, ARKO ORX DHEA, and WT ORX) mice compared with WT sham mice (Figs. 2 and 3) . Furthermore, cleaved caspase-3 and caspase-8 were abundant in the extracellular vesicles secreted by serous salivary epithelial cells in androgen-deficient mice. However, to our surprise, we could not detect nuclear expression of active caspases or any apoptotic cells with the TUNEL labeling. This is interesting, because it is known that nuclear localization of active effector caspases (42), including caspase-3 (16), is required for DNA fragmentation. This is part of caspase cascade leading to cell apoptosis, where initiator caspases (caspase-2, -8, -9, and -10) activate effector caspases (caspase-1, -3, -6, and -7), which in turn cleave intranuclear substrates, resulting in DNA fragmentation and cell shrinkage (38) . With this in mind, one possible explanation for our results is that in the absence of androgen activity apoptosis is initiated in serous epithelial cells of mouse SMGs through strong induction of the caspase cascade. Because this would result in a quick destruction of SMGs, we propose that cells are rescued from cell death by excretion of activated caspases out from cells via secreted extracellular vesicles, most likely exosomes. In support, our TEM results in ARKO ORX mice demonstrated secretory vesicles corresponding to the size of exosomes (Fig. 4) . Indeed, salivary gland epithelial cells have been shown in vitro to secrete exosomes (17) . Exosomes are involved in unconventional protein secretion (27) , and proteomic analysis of salivary gland exosomes actually showed that some of the exosomal proteins were associated with proapoptotic activities (8) .
With the growing knowledge of their function, exosomes have recently been implicated as promising tools in diagnostic and therapeutic applications (2, 28, 39) . Herein, we propose still another, up-to-date, undescribed protective antiapoptotic role of exosomes worth further analysis.
The serous salivary epithelial cells, known as granular convoluted tubules, are androgen-regulated dimorphic structures characteristic for rodents, being large in the adult male and small and fewer in the adult female (9, 20) . Similar to human serous acinar cells, these cells synthesize and excrete neutral mucopolysaccharides and a variety of biologically active polypeptides, including amylase (5, 20) . In this regard, reduced amylase and PAS staining (Figs. 5 and 6) and reduced number of intracellular secretory granules (observed with TEM) in androgen effect-deficient mice revealed disrupted function of serous salivary epithelial cells (Fig. 7) , implying an important role of androgens in normal functioning of SMGs.
In male exocrine tissue, e.g., salivary glands, testosterone can be easily converted to DHT in an intracrine process by 5␣-reductase type I (37) . In females, the situation is more complicated, and their DHT production relies solely on a prohormone DHEA. DHEA is synthesized in the reticular zone of the adrenal cortex, after which it is in peripheral tissues converted to DHT in a process involving more than 10 different enzyme isoforms and complex metabolic pathways (23) . Importantly, female patients with primary SS often display a decreased DHEA synthesis and/or deranged steroidogenic intracrine enzymatic machinery in exocrine salivary glands (37) . Furthermore, they show low expression of androgen-regulated CRISP-3 (22) , suggesting an incapability to locally convert DHEA prohormone to DHT in a complicated intracrine process (29) . This deficient DHT production could contribute to the initiation of the immune reaction against salivary gland epithelial cells in women.
Because of the DHEA-producing reticular zone of the adrenal gland, present only in man and other primates but absent in rodents (including mice used in this study as an animal model), it would be possible to explain why not all males and why only some females would be subjected to epithelial salivary gland cell apoptosis. It is also important to note that rodents do have an enzymatic machinery required for the conversion of DHEA into estrogens and/or androgens in the peripheral target tissues (23) .
An important finding of this study, consistent with our prediction, is that DHEA can rescue SMG phenotype in androgen-deficient WT ORX mice and that this process is apparently mediated through the AR. First, we showed that DHEA treatment inhibited expression of cleaved caspase-3 and caspase-8 in WT ORX mice, revealing an antiapoptotic effect of DHEA in SMGs (Figs. 2 and 3) . Next, we showed that DHEA treatment restored the serous salivary epithelial cell structure and function, demonstrated by mucin (PAS) and amylase content, which were maintained by DHEA treatment (Figs. 5 and 6 ), as well as the presence of intracellular secretory granules (Fig. 7) . In contrast to WT ORX mice, antiapoptotic and SMG-restoring DHEA effects were not observed in ARKO ORX mice, where AR was inactivated. Earlier, we showed that DHT is responsible for induction of androgen-regulated marker CRISP-3 in human HSG cells (29) , in accord with earlier findings in rodents (10, 11, 33) . Thus, upregulation of CRISP-3 in WT ORX DHEA mice in this study (Fig. 8) further supported idea that the antiapoptotic effect of DHEA in WT ORX mice was due to intracrine conversion of DHEA to active androgen. Accordingly, estrogen-regulated marker LIV-1 was mostly negative in both ARKO ORX and in DHEA-treated WT ORX mice. LIV-1 was slightly induced in serous salivary epithelial cells in ARKO ORX DHEA mice (Fig. 9) , suggesting that in the absence of ARs DHEA is eventually to some extent converted to estrogens.
Salivary glands from SS patients exhibit increased apoptosis of ductal epithelial and acinar cells (18, 24) . Caspase-3 was suggested to be involved in this process based on its upregulation in salivary epithelial cells in SS patients and NOD mice (25) . Our results support this idea and further suggest that androgens are crucial for the well being of SMGs. However, it seems that the enormous induction of proapoptotic caspase-8 and caspase-3 is according to impaired mucin and amylase staining harmful to serous salivary epithelial cells. However, these androgen-deficient cells seem to escape apoptosis by utilizing a nonconventional exosomal excretion of the deadly molecular caspase machinery. Therefore, at least in this model, androgen deficiency does not directly lead to apoptotic death of the serous salivary epithelial cells. If androgen deficiency contributes to focal autoimmune adenitis (and SS-like conditions in experimental models and SS patients), it seems to be via release and subsequent presentation of autoantigens (such as caspase-cleaved SS-A/B containing ribonucleoproteins and ␣-fodrin) by the ductal epithelial cells to T and B cells (31) .
In conclusion, our data suggest that 1) DHT can inhibit in vitro-induced SMG cell death, which escapes the apoptosis via a novel antiapoptotic mechanism that involves packaging and exosomal excretion of the already-activated caspases into saliva in membrane particles, 2) androgen deficiency activates the apoptotic caspase cascade in the serous salivary gland epithelial cells in mice SMGs, 3) DHEA prohormone exerts a protective effect, prevents the activation of the caspase cascade, and maintains the normal secretory phenotype of epithelial HSG cells, 4) DHEA acts antiapoptotically and can restore structure and function of SMG serous cells in androgendeficient mice, 5) and DHEA seems to act via its conversion to active androgen DHT and through the AR.
